While GLP-1 receptor agonists lead today’s headlines, peptide therapeutics continue expanding across endocrine, oncology and imaging indications. Veloxity Labs supports peptide programs with LC-MS/MS methods and phase-appropriate documentation designed around the analyte, matrix and development stage.
Our experienced team has supported hundreds of peptide programs, helping sponsors address selectivity, sensitivity and timeline requirements with fit-for-purpose bioanalytical approaches.